Divarasib
Divarasib (GDC-6036) is a potent, selective, and oral KRAS G12C inhibitor with sub-nanomolar IC50, which irreversibly traps the oncoprotein in an inactive state to suppress tumor growth. It is actively researched in vitro and in vivo for treating solid tumors such as non-small cell lung cancer and colorectal cancer.
Product Specifications
CAS Number
2417987-45-0
Product Name Alternative
Divarasib, KRAS G12C, GDC6036, GDC-6036, GDC 6036
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Purity
98.79% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween-80+45% Saline:3.3 mg/mL (5.3 mM) ; DMSO:90 mg/mL (144.68 mM)
Smiles
C[C@H]1CN (CCN1c1nc (OC[C@@H]2CCCN2C) nc2c (F) c (c (Cl) cc12) -c1nc (N) cc (C) c1C (F) (F) F) C (=O) C=C
Molecular Formula
C29H32ClF4N7O2
Molecular Weight
622.06
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7152625 Inquire
Rabbit anti-Legionella pneumophila Zinc metalloproteinase Polyclonal Antibody
Sign In for Pricing
View Details 
808474 1 Card (1 Panel (s) x 1 Pack)
PIC 262-N-A5-B7527 Personal Protection (PPE) Signs (No Adhesive)
Sign In for Pricing
View Details 